提供蛋白质的生物材料:临床翻译的机遇和挑战
Amogh Gorantla1, Jacques T V E Hall2, Anneliese Troidle3
1Department of Engineering, Wake Forest University, Winston-Salem, NC 27109, USA.
Micromachines
|April 27, 2024
概括
用于提供蛋白质的生物材料显示出治疗的希望,但面临着挑战. 诸如刺激响应材料和3D打印等创新推进了蛋白质疗法,但临床翻译需要克服生物相容性和传递障碍.
科学领域:
- 材料科学 材料科学 材料科学
- 生物工程是生物工程.
- 医学 医学 医学 医学 医学
背景情况:
- 蛋白质输送系统对于治疗应用至关重要.
- 生物材料为先进的蛋白质输送提供了一个有希望的平台.
研究的目的:
- 审查生物材料在提供蛋白质方面的潜力.
- 讨论该领域的挑战和进展.
- 探索临床翻译的障碍.
主要方法:
- 关于当前蛋白质传递生物材料的进展的文献综述.
- 对刺激反应材料的分析,3D打印和纳米技术的整合.
- 对临床翻译障碍的讨论.
主要成果:
- 响应刺激的材料,3D打印和纳米技术增强了蛋白质的传递.
- 需要复杂的输送系统来保持蛋白质的完整性.
- 临床转化存在重大障碍,包括生物相容性,免疫性,受控释放,向性,稳定性,可扩展性和监管问题.
结论:
- 生物材料在蛋白质治疗方面具有重大潜力.
- 克服设计,交付和制造方面的挑战是临床成功的关键.
- 需要进一步的创新来弥合研究和临床应用之间的差距.
相关概念视频
Recombinant DNA
Overview
Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug absorption...
Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.


